Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study-Reference-Cited by-同舟云学术

Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study

Published:2014-05 Issue:5 Volume:85 Page:1214-1224
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Niewczas Monika A.,Sirich Tammy L.,Mathew Anna V.,Skupien Jan,Mohney Robert P.,Warram James H.,Smiles Adam,Huang Xiaoping,Walker Walker,Byun Jaeman,Karoly Edward D.,Kensicki Elizabeth M.,Berry Gerard T.,Bonventre Joseph V.,Pennathur Subramaniam,Meyer Timothy W.,Krolewski Andrzej S.

Publisher

Elsevier BV

Subject

Nephrology

Reference77 articles.

1. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health;US Renal Data System,2010

2. Analytical approaches to metabolomics and applications to systems biology;Wang;Semin Nephrol,2010

3. Metabolomics as an extension of proteomic analysis: study of acute kidney injury;Portilla;Semin Nephrol,2007

4. Organization of GC/MS and LC/MS metabolomics data into chemical libraries;Dehaven;J Cheminform,2010

5. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems;Evans;Anal Chem,2009

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics Characterization of Disease Markers in Diabetes and Its Associated Pathologies;Metabolic Syndrome and Related Disorders;2024-09-01

2. C-Mannosyl tryptophan is a novel biomarker for thrombocytosis of myeloproliferative neoplasms;Scientific Reports;2024-08-14

3. Phenylsulfate-induced oxidative stress and mitochondrial dysfunction in podocytes are ameliorated by Astragaloside IV activation of the SIRT1/PGC1α /Nrf1 signaling pathway;Biomedicine & Pharmacotherapy;2024-08

4. Metabolomics in diabetic nephropathy: Unveiling novel biomarkers for diagnosis (Review);Molecular Medicine Reports;2024-07-03

5. Advancements, Challenges, and clinical implications of integration of metabolomics technologies in diabetic nephropathy;Clinica Chimica Acta;2024-07